|
US20080261289A1
(en)
*
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
US6544769B1
(en)
*
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
CA2353417C
(en)
*
|
1998-12-03 |
2008-04-22 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6225289B1
(en)
*
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
FR2791999B1
(fr)
*
|
1999-04-09 |
2001-09-07 |
Aventis Pharma Sa |
Composition destinee a la conservation d'adenovirus recombinants infectieux
|
|
HK1045716A1
(zh)
|
1999-04-09 |
2002-12-06 |
阿文蒂斯药物股份有限公司 |
用於保存感染性重組腺病毒的組合物
|
|
EP1263461A4
(en)
|
2000-03-07 |
2009-08-12 |
Merck & Co Inc |
ADENOVIRUS FORMULATIONS
|
|
US7456009B2
(en)
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
WO2001085928A1
(en)
*
|
2000-05-10 |
2001-11-15 |
Mitsubishi Pharma Corporation |
Method of preparing virus vector
|
|
JP2005517394A
(ja)
|
2001-12-12 |
2005-06-16 |
エフ エイチ フォールディング アンド カンパニー リミテッド |
ウイルス保存のための組成物
|
|
EP1465664A1
(en)
*
|
2002-01-18 |
2004-10-13 |
Schering Aktiengesellschaft |
Stabilized formulations of adenovirus
|
|
KR100507794B1
(ko)
*
|
2003-02-11 |
2005-08-17 |
한미약품 주식회사 |
고농도 레트로 바이러스 현탁액 제조 방법
|
|
US20070148765A1
(en)
*
|
2003-11-19 |
2007-06-28 |
Evans Robert K |
Preservative-containing virus formulations
|
|
DE602005015332D1
(de)
*
|
2004-02-23 |
2009-08-20 |
Crucell Holland Bv |
Verfahren zur Reinigung von Viren
|
|
GB0502661D0
(en)
*
|
2005-02-09 |
2005-03-16 |
Stabilitech Ltd |
A desiccated product
|
|
EP1869171B2
(en)
*
|
2005-04-11 |
2015-10-14 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
CN1961961B
(zh)
*
|
2005-11-11 |
2010-05-26 |
深圳市源兴生物医药科技有限公司 |
一种药物制剂及其制备方法
|
|
ES2532015T3
(es)
|
2008-11-03 |
2015-03-23 |
Crucell Holland B.V. |
Método para la producción de vectores adenovíricos
|
|
AU2011214262B2
(en)
|
2010-02-15 |
2015-05-21 |
Crucell Holland B.V. |
Method for the production of Ad26 adenoviral vectors
|
|
WO2012038367A1
(en)
|
2010-09-20 |
2012-03-29 |
Crucell Holland B.V. |
Therapeutic vaccination against active tuberculosis
|
|
BR112013004582A2
(pt)
|
2010-09-27 |
2016-09-06 |
Crucell Holland Bv |
método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária
|
|
CN103269716B
(zh)
*
|
2010-12-02 |
2015-05-27 |
昂科利蒂克斯生物科技公司 |
冻干病毒制剂
|
|
CA2819246C
(en)
|
2010-12-02 |
2023-04-25 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
CN104379733B
(zh)
|
2012-03-12 |
2016-01-20 |
克鲁塞尔荷兰公司 |
具改变末端的重组腺病毒群
|
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
BR112014023196B1
(pt)
|
2012-03-22 |
2021-09-08 |
Janssen Vaccines & Prevention B.V. |
Vacinas contra o vírus sincicial respiratório (rsv), seu método de produção, e ácido nucleico recombinante isolado
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
SG11201500171YA
(en)
|
2012-07-10 |
2015-02-27 |
Transgene Sa |
Mycobacterial antigen vaccine
|
|
HUE041659T2
(hu)
|
2013-04-25 |
2019-05-28 |
Janssen Vaccines & Prevention Bv |
Stabilizált oldható pre-fúziós RSV F polipeptidek
|
|
MX362792B
(es)
|
2013-06-17 |
2019-02-13 |
Janssen Vaccines & Prevention Bv |
Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados.
|
|
CN106103471B
(zh)
|
2014-01-09 |
2020-01-07 |
特兰斯吉恩股份有限公司 |
异源寡聚分枝杆菌抗原的融合
|
|
US9721484B2
(en)
|
2014-06-23 |
2017-08-01 |
Humanetics Innovative Solutions, Inc. |
Shoulder kit assembly for crash test dummy
|
|
CA3190510A1
(en)
|
2014-07-16 |
2016-01-21 |
Transgene Sa |
Oncolytic virus for expression of immune checkpoint modulators
|
|
US10008130B2
(en)
|
2014-09-17 |
2018-06-26 |
Humanetics Innovative Solutions, Inc. |
Omni-directional shoulder assembly for crash test dummy
|
|
US20180028626A1
(en)
|
2015-02-13 |
2018-02-01 |
Transgene Sa |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
CN107466324B
(zh)
|
2015-04-14 |
2022-01-14 |
扬森疫苗与预防公司 |
具有双向启动子的表达两种转基因的重组腺病毒
|
|
PL3319633T3
(pl)
|
2015-07-07 |
2021-04-19 |
Janssen Vaccines & Prevention B.V. |
Szczepionka przeciwko rsv
|
|
CN107847581B
(zh)
|
2015-07-07 |
2022-03-22 |
扬森疫苗与预防公司 |
稳定化的可溶性融合前rsv f多肽
|
|
BR112018070323A2
(pt)
|
2016-04-05 |
2019-01-29 |
Janssen Vaccines & Prevention Bv |
vacina contra rsv
|
|
SG11201807913XA
(en)
|
2016-04-05 |
2018-10-30 |
Janssen Vaccines & Prevention Bv |
Stabilized soluble pre-fusion rsv f proteins
|
|
MX388872B
(es)
|
2016-05-12 |
2025-03-20 |
Janssen Vaccines & Prevention Bv |
Promotor bidireccional potente y equilibrado.
|
|
BR112018074483A2
(pt)
|
2016-05-30 |
2019-03-19 |
Janssen Vaccines & Prevention B.V. |
proteínas f do rsv pré-fusão estabilizadas
|
|
KR102307065B1
(ko)
|
2016-06-20 |
2021-09-30 |
얀센 백신스 앤드 프리벤션 비.브이. |
강력하고 균형 잡힌 양방향성 프로모터
|
|
WO2018011196A1
(en)
|
2016-07-14 |
2018-01-18 |
Janssen Vaccines & Prevention B.V. |
Hpv vaccines
|
|
TW201825674A
(zh)
|
2016-09-09 |
2018-07-16 |
美商艾斯合顧問有限公司 |
表現雙特異性接合分子的溶瘤病毒
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
WO2018122088A1
(en)
|
2016-12-28 |
2018-07-05 |
Transgene Sa |
Oncolytic viruses and therapeutic molecules
|
|
KR102111244B1
(ko)
|
2017-02-09 |
2020-05-15 |
얀센 백신스 앤드 프리벤션 비.브이. |
이종 유전자의 발현을 위한 강력한 짧은 프로모터
|
|
CA3061278A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
WO2018210871A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
KR20200053518A
(ko)
|
2017-09-15 |
2020-05-18 |
얀센 백신스 앤드 프리벤션 비.브이. |
Rsv에 대한 면역의 안전한 유도를 위한 방법
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
US12263197B2
(en)
|
2018-10-30 |
2025-04-01 |
The University Of Tokyo |
Oncolytic virus for cancer therapy
|
|
CR20210306A
(es)
|
2018-11-13 |
2021-07-22 |
Janssen Vaccines & Prevention Bv |
Proteínas f de prefusión del vrs estabilizadas
|
|
TW202204380A
(zh)
|
2020-01-31 |
2022-02-01 |
美商詹森藥物公司 |
用於預防及治療冠狀病毒感染之組合物及方法－sars-cov-2疫苗
|
|
AU2021237818A1
(en)
|
2020-03-19 |
2022-09-29 |
Ferring Ventures Ltd. |
Temperature-responsive virus storage system
|
|
EP4178605A1
(en)
|
2020-07-13 |
2023-05-17 |
Transgene |
Treatment of immune depression
|
|
KR20230152035A
(ko)
|
2021-02-01 |
2023-11-02 |
에쓰티 피에이치아이 테라퓨틱스 컴퍼니 리미티드 |
표적 단백질 분해 시스템 및 이의 응용
|
|
MX2023009738A
(es)
|
2021-02-19 |
2023-08-30 |
Janssen Vaccines & Prevention Bv |
Antigenos de rsv fb prefusion estabilizados.
|
|
WO2023020939A1
(en)
|
2021-08-17 |
2023-02-23 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023025899A2
(en)
|
2021-08-26 |
2023-03-02 |
Transgene |
Delivery system for targeting genes of the interferon pathway
|
|
WO2023111725A1
(en)
|
2021-12-14 |
2023-06-22 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
|
JP2025523573A
(ja)
|
2022-07-01 |
2025-07-23 |
トランジェーヌ |
サーファクタントタンパク質－ｄとｔｎｆｓｆのメンバーを含んでなる融合タンパク質
|
|
KR20250052416A
(ko)
|
2022-08-18 |
2025-04-18 |
트랜스진 |
키메라 폭스바이러스
|